Pascual, A C <br/><br/>
Normal aging in rats and pathological aging in human Alzheimer's disease decrease FAAH activity: modulation by cannabinoid agonists.  [electronic resource] 

 -  Experimental gerontology  Dec 2014 
 - 92-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-6815 
<br/><br/><label>Standard No.: </label>10.1016/j.exger.2014.10.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Aging--metabolism<br/>Alzheimer Disease--drug therapy<br/>Amidohydrolases--antagonists & inhibitors<br/>Amyloid beta-Peptides--metabolism<br/>Animals<br/>Arachidonic Acids--metabolism<br/>Benzamides--pharmacology<br/>Benzoxazines--pharmacology<br/>Cannabinoid Receptor Agonists--pharmacology<br/>Cannabinoids--pharmacology<br/>Carbamates--pharmacology<br/>Case-Control Studies<br/>Cerebral Cortex--drug effects<br/>Endocannabinoids--metabolism<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Frontal Lobe--drug effects<br/>Humans<br/>In Vitro Techniques<br/>Male<br/>Middle Aged<br/>Morpholines--pharmacology<br/>Naphthalenes--pharmacology<br/>Polyunsaturated Alkamides--metabolism<br/>Rats<br/>Rats, Wistar<br/>Synaptosomes--drug effects